Fangzheng Valve Group
920082
Air China Cargo
001391
LINTEX
920106
BBK Test Systems
301598
Zhejiang E-P Equipment
603194
CN Stock MarketDetailed Quotes
688271 Shanghai United Imaging Healthcare
- 127.36
- 0.000.00%
Not Open Dec 27 09:30 CST
104.96BMarket Cap66.37P/E (TTM)
0.00High0.00Low0lotVolume0.00Open127.36Pre Close0.00Turnover0.00%Turnover Ratio53.16P/E (Static)824.16MShares151.8852wk High5.46P/B75.56BFloat Cap91.8852wk Low152.83Limit Up593.30MShs Float217.43Historical High101.89Limit Down0.00%Amplitude91.88Historical Low0.37Dividend TTM--Avg Price0lotAsk0.29%Div YieldTTM100Lot Size0lotBid
Shanghai United Imaging Healthcare Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.43%6.95B | 1.18%5.33B | 6.22%2.35B | 23.52%11.41B | 26.86%7.43B | 26.35%5.27B | 33.42%2.21B | 27.36%9.24B | 25.55%5.86B | 35.23%4.17B |
| Operating revenue | -6.43%6.95B | 1.18%5.33B | 6.22%2.35B | 23.52%11.41B | 26.86%7.43B | 26.35%5.27B | 33.42%2.21B | 27.36%9.24B | 25.55%5.86B | 35.23%4.17B |
| Total operating cost | -1.81%6.61B | -0.24%4.56B | 5.44%2.06B | 26.80%9.86B | 31.23%6.73B | 33.18%4.58B | 40.46%1.95B | 29.48%7.77B | 27.63%5.13B | 36.19%3.44B |
| Operating cost | -7.79%3.52B | -2.09%2.65B | 7.68%1.19B | 23.24%5.88B | 20.15%3.82B | 20.35%2.7B | 31.51%1.1B | 30.02%4.77B | 38.17%3.18B | 50.63%2.25B |
| Operating tax surcharges | -22.02%36.56M | -20.43%27.17M | -40.16%11.87M | 81.20%69.49M | 126.25%46.88M | 232.78%34.15M | 228.23%19.84M | -11.08%38.35M | -20.27%20.72M | -46.75%10.26M |
| Operating expense | 10.55%1.39B | 8.17%891.37M | 6.98%357.71M | 33.28%1.77B | 43.52%1.25B | 55.90%824.04M | 34.12%334.36M | 28.98%1.33B | 15.96%873.17M | 20.74%528.57M |
| Administration expense | 8.36%411.74M | -3.18%238.74M | 4.41%121.18M | 30.22%560.71M | 39.62%379.97M | 48.63%246.6M | 45.49%116.06M | 34.92%430.6M | 20.56%272.16M | 24.26%165.91M |
| Financial expense | 54.83%-60.91M | 44.40%-65.35M | -18.27%-40.69M | -50.81%-148.89M | -66.42%-134.85M | -456.44%-117.52M | -248.71%-34.4M | -304.12%-98.73M | -331.96%-81.03M | -51.29%-21.12M |
| -Interest expense (Financial expense) | -1.51%5.15M | -0.37%3.42M | -46.36%703.53K | 9.31%7.02M | 12.02%5.23M | -7.66%3.43M | -16.54%1.31M | 13.39%6.42M | 23.81%4.67M | 10.87%3.72M |
| -Interest Income (Financial expense) | 36.25%-91.79M | 29.92%-70.97M | 18.34%-39.21M | -82.97%-174.67M | -152.40%-143.99M | -481.57%-101.27M | -437.60%-48.02M | -239.21%-95.47M | -112.33%-57.05M | -13.74%-17.41M |
| Research and development | -3.79%1.32B | -6.69%826.02M | 1.75%419.68M | 32.33%1.73B | 57.79%1.37B | 75.00%885.23M | 83.06%412.46M | 34.90%1.31B | 18.23%867.97M | 11.19%505.84M |
| Credit Impairment Loss | -7,656.59%-107.93M | -311.12%-73.49M | -87.02%-25.58M | 37.58%-58.98M | 102.30%1.43M | 153.93%34.81M | 49.94%-13.68M | -390.06%-94.49M | -85.68%-62.01M | -189.16%-64.55M |
| Asset Impairment Loss | 1,199.86%50.46M | 2,892.52%39.52M | 113.52%2.08M | 42.62%-42.89M | 73.29%-4.59M | 108.69%1.32M | -40.76%-15.39M | -196.64%-74.75M | 14.97%-17.18M | -27.27%-15.19M |
| Other net revenue | ||||||||||
| Fair value change income | 111.45%634.72K | 205.13%7.41M | -40.37%7.8M | -121.27%-6.06M | -539.95%-5.54M | -10,632.64%-7.05M | 36,020.01%13.08M | 369.18%28.5M | 138.39%1.26M | -96.55%66.92K |
| Invest income | -11.05%72.24M | -7.86%45.03M | 111.93%15.5M | 771.12%110.35M | 3,191.90%81.21M | 3,584.52%48.87M | 461.87%7.31M | -79.65%12.67M | -106.96%-2.63M | -90.93%1.33M |
| -Including: Investment income associates | 23.35%-9.11M | 48.01%-6.81M | -38.74%-4.35M | -107.46%-15.87M | 6.64%-11.89M | -54.69%-13.1M | 33.06%-3.14M | -150.44%-7.65M | -9.51%-12.74M | -0.90%-8.47M |
| Asset deal income | 4,529.95%623.35K | 4,526.66%622.91K | ---- | 2,412.36%13.46K | 2,412.36%13.46K | 2,412.36%13.46K | -97.16%20.82K | 99.67%-582.24 | -100.35%-582.24 | -100.73%-582.24 |
| Other revenue | -8.65%355.17M | -7.54%252.5M | -2.61%105.26M | -1.03%586.27M | 5.04%388.82M | 21.17%273.1M | -16.26%108.08M | 34.76%592.37M | 23.42%370.17M | 8.19%225.39M |
| Adjusted Items effecting operating profit | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -38.38%717.19M | -0.59%1.04B | 10.24%400.41M | 11.06%2.14B | 14.12%1.16B | 18.48%1.05B | 0.73%363.21M | 13.68%1.93B | 9.76%1.02B | 17.28%883.21M |
| Add:Non operating Income | -65.81%3.63M | -81.23%1.55M | 25.93%950.37K | 332.30%10.53M | 522.84%10.63M | 785.41%8.27M | 137.15%754.67K | -76.75%2.44M | -78.01%1.71M | -87.09%933.7K |
| Less:Non operating expense | 11.99%8.96M | -72.81%2.01M | -63.42%1.62M | -10.02%9.79M | -9.59%8M | 6.20%7.41M | -23.68%4.42M | 20.04%10.88M | 11.94%8.85M | 181.02%6.97M |
| Add:Adjusted items effecting total profit | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total profit | -38.97%711.86M | -0.71%1.04B | 11.18%399.74M | 11.59%2.14B | 15.18%1.17B | 19.39%1.05B | 1.25%359.54M | 13.09%1.92B | 9.01%1.01B | 15.75%877.18M |
| Less:Income tax cost | -46.99%53.47M | -11.48%95.23M | 11.13%37.8M | -39.01%164.5M | -24.32%100.87M | -9.56%107.58M | -36.33%34.01M | -8.27%269.71M | -22.37%133.29M | 0.58%118.96M |
| Net profit | -38.21%658.39M | 0.52%944.57M | 11.19%361.94M | 19.86%1.98B | 21.17%1.07B | 23.94%939.7M | 7.90%325.53M | 17.57%1.65B | 16.13%879.42M | 18.55%758.21M |
| Net profit from continuing operation | -38.21%658.39M | 0.52%944.57M | 11.19%361.94M | 19.86%1.98B | 21.17%1.07B | 23.94%939.7M | --325.53M | 17.57%1.65B | 16.13%879.42M | --758.21M |
| Less:Minority Profit | -1,099.91%-12.77M | -394.01%-5.65M | 67.20%-1.36M | 157.72%3.46M | 106.59%1.28M | 112.30%1.92M | 7.39%-4.13M | 56.14%-6M | -44.24%-19.39M | -98.79%-15.62M |
| Net profit of parent company owners | -36.94%671.16M | 1.33%950.21M | 10.20%363.3M | 19.21%1.97B | 18.41%1.06B | 21.19%937.78M | 7.68%329.66M | 16.86%1.66B | 16.62%898.8M | 19.52%773.83M |
| Earning per share | ||||||||||
| Basic earning per share | -36.43%0.82 | 1.75%1.16 | 10.00%0.44 | 9.59%2.4 | 5.74%1.29 | 6.54%1.14 | -4.76%0.4 | 11.73%2.19 | 15.09%1.22 | 20.22%1.07 |
| Diluted earning per share | -36.43%0.82 | 1.75%1.16 | 10.00%0.44 | 9.59%2.4 | 5.74%1.29 | 6.54%1.14 | -4.76%0.4 | 11.73%2.19 | 15.09%1.22 | 20.22%1.07 |
| Other composite income | -256.16%-7.86M | -82.47%2.23M | 121.74%1.05M | -36.23%13.75M | -60.83%5.03M | 27.92%12.74M | 8.72%-4.81M | 180.96%21.56M | 281.26%12.84M | 1,425.32%9.96M |
| Other composite income of parent company owners | -256.16%-7.86M | -82.47%2.23M | 121.74%1.05M | -36.23%13.75M | -60.83%5.03M | 27.92%12.74M | 8.72%-4.81M | 180.96%21.56M | 281.26%12.84M | 1,425.32%9.96M |
| Total composite income | -39.24%650.53M | -0.59%946.8M | 13.18%362.99M | 19.13%1.99B | 19.99%1.07B | 23.99%952.44M | 8.20%320.72M | 21.41%1.67B | 18.93%892.26M | 20.25%768.17M |
| Total composite income of parent company owners | -37.97%663.31M | 0.20%952.45M | 12.16%364.34M | 18.50%1.99B | 17.29%1.07B | 21.27%950.52M | 7.97%324.85M | 20.65%1.68B | 19.38%911.65M | 21.20%783.79M |
| Total composite income of minority owners | -1,099.91%-12.77M | -394.01%-5.65M | 67.20%-1.36M | 157.72%3.46M | 106.59%1.28M | 112.30%1.92M | 7.39%-4.13M | 56.14%-6M | -44.24%-19.39M | -98.79%-15.62M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.